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Preface 
Attention Deficit Hyperactivity Disorder (ADHD) is a highly heritable, disabling 
condition that commonly persists into adulthood. Main features are symptoms of 
inattention, hyperactivity and impulsivity. The disorder is considered to be 
multifactorial and heterogeneous, and this complexity is reflected in this thesis by the 
inclusion of articles covering a range of issues concerning the nature of the disorder. 
The included studies all examine research questions that are relevant for our 
understanding of executive functioning in ADHD. The project “ADHD in Norwegian 
adults; from clinical characterization to molecular mechanisms” was established in 
2004. At that time, relatively little was known about ADHD in adults, and there was 
an urgent need for more knowledge about this common psychiatric disorder. ADHD 
is characterized by severe functional impairments for those affected, with 
implications for the family and society. However, the disorder is clinically 
heterogeneous and probably has a multifactorial aetiology. This heterogeneity 
complicates doing research on ADHD, and what we call ADHD today might look 
different in the future as the field of psychiatric research is evolving. To take part in 
this process has been exciting. Although ADHD as a clinical entity has been 
recognized for a long time, the validity of the diagnosis is still frequently discussed in 
the media. This makes it even more difficult for patients and their relatives to cope 
with the impairments of the disorder. Although most people at some time may have 
some of the features of ADHD, it is required to be an impairing condition with early 
onset to fulfil the current diagnostic criteria. Most of the ADHD patients we meet in 
the clinic struggle with significant functional impairment, which is also well 
documented in the literature. To obtain more knowledge and to help this group of 
people is therefore a meaningful work, and I am grateful that I got the opportunity to 
take part in this.  
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Abstract 
Background  
Attention deficit hyperactivity disorder (ADHD) is characterized by age inappropriate 
levels of hyperactivity, inattention and impulsivity. A large proportion of children 
with ADHD have persisting symptoms into adulthood. However, the pathways from 
genetic susceptibility to symptoms and functional outcomes of ADHD are still not 
well understood. Some researchers argue that impairment of executive function (EF) 
is an essential part of the disorder. The present thesis was motivated by the need of 
more research to understand the genetics of EF, how to measure EF, the 
heterogenetiy of EF and the functional outcomes of deficit of EF (EFD) in ADHD. In 
the first study included in this thesis, we used a dimensional approach to investigate 
COMT haplotypes and symptoms of ADHD, in addition to investigate genetic 
heterogeneity through the identification of potential subgroups within the disorder. 
The COMT gene has been shown to be important for the regulation of dopamine 
levels in prefrontal cortex, and has been associated with several asptects of EF, such 
as set shifting and inhibition. In the second study, we investigated these functions in 
ADHD, with the aim to obtain “pure” measures of EF. In the third study, these 
functions, in addition to other important EFs were included, and we investigated the 
heterogeneity of ADHD through characterizing functional impairment in the group 
with ADHD and psychometrically defined EFD.  
Materials and methods 
The thesis is based on three different papers. In the first paper, 435 participants with a 
clinical diagnosis of ADHD and 383 controls were included. The second paper 
included 60 participants with ADHD and 60 controls, while 79 participants with 
ADHD and 77 controls were included in the third paper. All participants filled in self-
report questionnaires and supplied blood or saliva samples for genetic analysis. The 
questionnaires included items to assess demographical and clinical data, in addition to 
levels of ADHD-symptoms in adulthood and childhood. Participants included in the 
two last papers also went through a neuropsychological examination and a psychiatric 
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interview. The neuropsychological assessment included tests from the Delis-Kaplan 
Executive Function System (D-KEFS), Wechsler Abbreviated Scale of Intelligence 
(WASI) and Paced Auditory Serial Addition Task (PASAT).  
Results 
We found that COMT haplotypes were significantly associated with dimensional 
hyperactivity/impulsivity symptoms with a stepwise decreased score associated with 
the mid and low activity haplotypes. When stratifying for use of medication, the 
significance was only kept for hyperactivity in the subgroup of medicated ADHD 
patients. There was no significant association between COMT and measures of 
impulsivity. In the second paper, we found that participants with ADHD scored 
significantly lower than the control group on set shifting as measured with a subtest 
from the Colour-Word Interference Test (CWIT) from D-KEFS, also after control for 
basic functions, working memory and IQ. In the third paper, we found that the 
participants with ADHD and neuropsychologically defined EFD were characterized 
by a higher degree of functional impairment than those without EFD, including more 
reading and writing problems, lower IQ, more ADHD symptoms in childhood and 
lower work participation.       
Conclusions 
Our data show that examining COMT haplotypes may be useful to understand basic  
mechanisms in ADHD and the heterogeneity of the disorder. The second study 
indicates that set shifting as measured with the CWIT from D-KEFS may act as a 
potential endophenotype for ADHD. The third study, in line with the first one, 
supported that ADHD is a heterogeneous condition by showing that the group with 
ADHD and EFD combined may be a distinct subgroup characterized by a high level 
of functional impairment.  
 
The results in the present thesis suggest that set shifting measures from D-KEFS 
should be included in the definition of EFD. Future studies should examine groups 
with and without psychometrically defined EFD, both at a genetic and psychosocial 
level, as the identification of such subgroups could lead to more targeted and 
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effective treatment.  
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1. Introduction 
1.1 Historical perspective 
Symptoms and behaviour similar to what is currently recognized as part of ADHD 
have been described in fictional and scientific literature throughout history. As early 
as in 1775, the German physician Melchior Adam Weikard described a condition 
similar to the inattentive type of ADHD in the Fifth Edition of the Diagnostic and 
Statistical Manual of Mental Disorders (DSM-5) (American Psychiatric Association, 
2013). He recommended cold baths, steel powder, mineral waters, gymnastic 
exercises and horseback riding as potential treatments (Barkley & Peters, 2012). In 
1798, the Scottish physician Alexander Crichton described alterations of attention 
and “mental restlessness” that corresponds to some of the symptom descriptions of 
Attention Deficit Hyperactivity Disorder (ADHD) in the DSM-IV (Crichton, 2008; 
Lange, Reichl, Lange, Tucha, & Tucha, 2010). Several years later, the German 
physician Hoffmann created the history about the misbehaving boy “Fidgety Phil” 
which is still today used as a popular allegory for children with ADHD (Lange et al., 
2010). Despite such early descriptions of ADHD-like symptoms, many authors 
consider the scientific starting point of the history of ADHD to be when the British 
paediatrician Sir George Frederic Still described children showing serious problems 
with sustained attention and linked this to difficulties with moral control (Lange et 
al., 2010; Still, 1902). In the beginning of the 20th century, the similarity between 
symptoms of ADHD and other neurological conditions lead to use of medical terms 
such as “Post-Encephalitic Behaviour Disorder” (S. Levy, 1959). The first effective 
treatment of hyperactivity in children was described by Charles Bradley in 1937 
(Bradley, 1937), and was a result of the growing notion that hyperactive behaviour 
was related to brain damage. A hypothesis about minimal brain damage causing 
behaviour disorders was therefore established (Lange et al., 2010). The term 
“minimal brain disorder” was substituted with “minimal brain dysfunction” in the 
early 1960s as it was recognized that many children without indication of brain 
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damage displayed the syndrome (Barkley, 2006). Before 1970, ADHD was 
considered mainly a childhood disorder. However, in 1976, two reports described 
symptoms and impairments also in adults and proposed that ADHD could persist into 
adulthood (Hechtman, Weiss, Finklestein, Werner, & Benn, 1976; Wood, Reimherr, 
Wender, & Johnson, 1976). The inclusion of attention deficit disorder (ADD) in 
DSM-III in 1980 (American Psychiatric Association, 1980), represented a major 
change in that attention deficit also was seen as a significant component of the 
disorder. In DSM-III, a residual type of ADHD was also introduced for individuals 
who had a history of meeting full criteria, but presently displayed fewer symptoms 
that still caused significant impairment. In the revised DSM-III from 1987, the term 
“Attention Deficit Hyperactivity Disorder” was introduced (American Psychiatric 
Association, 1987) describing ADHD as an uni-dimensional disorder. The inattentive 
subtype and the residual type were removed and replaced by a new, more vague 
category; “undifferentiated ADHD”. However, several studies were published 
supporting the validity of an inattentive subtype and the residual type of ADHD, and 
both were again included in the DSM-IV (American Psychiatric Association, 1994).  
1.2 What is ADHD? Diagnostic criteria and clinical features 
Today, the diagnostic manual DSM-5 (American Psychiatric Association, 2013), like 
the DSM-IV, describes ADHD as a condition that involves either 
hyperactivity/impulsivity, or inattention, or both. The diagnostic criteria applied in 
the studies included herein are from the version of DSM-IV-TR (American 
Psychiatric Association, 2000), and these criteria are therefore described in this 
thesis. In Europe, most countries use the International Classification of Diseases 
(ICD-10; World Health Organization, 2003), where symptoms from both dimensions 
must be present for the diagnosis to be given. However, the DSM-criteria are 
commonly used also outside the USA, to comply with the international standard.  
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No single test can confirm the diagnosis of ADHD, and the diagnostic criteria are 
descriptive in nature. It has also been discussed if the criteria are suitable for adults as 
they differ from children in symptom presentation (Kessler et al., 2010).  
The diagnosis is based on an interpretation where the clinician has to judge whether 
the symptoms are sufficiently strong and impairing to warrant a diagnosis.  
To diagnose ADHD, the DSM-IV requires the presence of 6 of 9 symptoms from 
either dimension (hyperactivity/impulsivity or inattention). If fulfilling criteria for 
both dimensions, ADHD combined type is diagnosed. There is also ADHD Not 
Otherwise Specified (NOS) that comprises disorders where inattention or 
hyperactivity is prominent, but not so impairing that the formal diagnostic criteria are 
met.  
 
1.2.1 Diagnostic criteria of Attention Deficit Hyperactivity Disorder 
according to DSM-IV 
The following description is adapted from the Diagnostic and Statistical Manual of 
Mental Disorders, fourth edition, text revision, American Psychiatric Association, 
2000 (American Psychiatric Association, 2000).  
A. Either (1) or (2): 
(1) Six (or more) of the following symptoms of inattention have persisted for at least 6 months to a degree 
that is maladaptive and inconsistent with developmental level: 
(a) Often fails to give close attention to details or makes careless mistakes in school-work, work, or other 
activities 
(b) Often has difficulty sustaining attention in tasks or play activities 
(c) Often does not seem to listen when spoken to directly 
(d) Often does not follow through on instructions and fails to finish schoolwork, chores, or duties in the 
workplace (not due to oppositional behaviour or failure to understand instructions) 
(e) Often has difficulty organizing tasks and activities 
(f) Often avoids, dislikes, or is reluctant to engage in tasks that require sustained mental effort (such as 
schoolwork and homework) 
(g) Often loses things necessary for task or activities (e.g., toys, school assignment, pencils, books, or tools) 
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(h) Is often easily distracted by extraneous stimuli 
(i) Is often forgetful in daily activities 
 
 (2) Six (or more) of the following symptoms of hyperactivity-impulsivity have persisted for at least 6 
months to a degree that is maladaptive and inconsistent with developmental level: 
Hyperactivity 
(a) Often fidgets with hands or feet or squirms in seat 
(b) Often leaves seat in classroom or in other situation in which remaining seated is expected 
(c) Often runs about or climbs excessively in situations in which it is inappropriate (in adolescents or adults, 
may be limited to subjective feelings of restlessness) 
(d) Often has difficulty playing or engaging in leisure activities quietly 
(e) Is often “on the go” or often acts as if “driven by a motor” 
(f) Often talks excessively 
Impulsivity 
(g) Often blurts out answers before questions have been completed 
(h) Often has difficulty awaiting turn 
(i) Often interrupts or intrudes on others (e.g. butts into conversation or games) 
B. Some hyperactive-impulsive or inattentive symptoms that cause impairment were present before age 7 
years. 
C. Some impairment from the symptoms is present in two or more settings (e.g., at school [or work] and at 
home). 
D. There must be clear evidence of clinically significant impairment in social, academic, or occupational 
functioning. 
E. The symptoms do not occur exclusively during the course of a Pervasive Developmental Disorder, 
Schizophrenia, or Psychotic Disorder and are not better accounted for by another mental disorder (e.g., Mood 
Disorder, Anxiety Disorder, Dissociative Disorder, or a Personality Disorder) 
 
In the DSM-5, the definition of ADHD has been updated to more accurately describe 
the adult condition. The age criteria of 7 years has been changed to 12 due to research 
showing no clinical differences between children identified by 7 years versus those 
identified later, for example with regard to treatment response, course and severity or 
outcome (American Psychiatric Association, 2013). While children must present with 
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at least six symptoms from one or both subgroup dimensions, for older adolescents 
and adults (over age 17 years) it is enough with five symptoms.  
1.3 Prevalence and persistence of adult ADHD 
ADHD is one of the most common diagnoses in child psychiatry. However, 
prevalence rates have varied a lot between different studies. Use of different methods 
and criteria may be one reason for the different estimates. For example, using the 
ICD-10 criteria, where the inattentive subtype is not included in the manual, will give 
lower prevalence estimates than DSM-IV or DSM-5. In addition, gender, type of 
sample studied, different informants and age also may influence the prevalence rates 
in different studies, which have been found to vary between 1% and 20% (Faraone, 
Sergeant, Gillberg, & Biederman, 2003). When only applying DSM criteria, 
estimates have varied from 1 to 7.3% (Simon, Czobor, Balint, Meszaros, & Bitter, 
2009). However, a pooled prevalence of 5.3% across studies worldwide has been 
found in a comprehensive review/meta-analysis (Polanczyk, de Lima, Horta, 
Biederman, & Rohde, 2007). 
Some years ago, ADHD was seen as a disorder of childhood, but it is now recognized 
that a large proportion of children with ADHD have persisting symptoms into 
adulthood (Faraone & Biederman, 2005; Lara et al., 2009; Mick, Faraone, & 
Biederman, 2004; P. Rasmussen & Gillberg, 2000). The exact persistence rate is not 
known, but several studies have shown that adults with ADHD have a high load of 
symptoms, in addition to significant functional impairment (Adamou et al., 2013; 
Gjervan, Torgersen, Nordahl, & Rasmussen, 2012; Halmoy, Fasmer, Gillberg, & 
Haavik, 2009; Kupper et al., 2012). However, symptoms in adults may be expressed 
differently than childhood symptoms. For example, with increasing age, overt 
symptoms of hyperactivity and impulsivity are found to decline (Biederman, Mick, & 
Faraone, 2000). Interestingly, while basal ganglia regions associated with 
hyperactivity have been shown to be reduced in children with ADHD (Frodl & 
Skokauskas, 2012; Qiu et al., 2009), no significant volumetric differences were found 
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in the basal ganglia in adults with ADHD compared to age-matched controls (Frodl & 
Skokauskas, 2012; Qiu et al., 2009). In line with this, studies have shown that the 
overt symptoms of hyperactivity in ADHD decrease with age (Biederman et al., 
2000). Several longitudinal studies have been conducted to investigate the persistence 
of ADHD from childhood to adulthood, and estimates of the proportions of children 
retaining the diagnosis in late adolescence/adulthood have varied between 8-72% (J. 
C. Hill & Schoener, 1996). However, the different versions of DSM may have 
influenced the results, as the earlier versions had most focus on hyperactivity. In 
longitudinal studies of children with ADHD, community surveys and epidemiological 
studies of population samples, the adult ADHD prevalence has been estimated to be 
2.5% (Simon et al., 2009). However, because of the different problems associated 
with assessment of prevalence in adult ADHD, more research is needed to estimate 
the proportion of adults that is affected by this condition.  
1.4 Neurobiology of ADHD 
The aetiology of ADHD is not fully understood, but several studies show that ADHD 
has neurobiological underpinnings (De La Fuente, Xia, Branch, & Li, 2013). Studies 
have shown a reduction of 4-5% in cerebellar and cerebral volume in children and 
adolescents with ADHD compared to controls (Carmona et al., 2005; Castellanos et 
al., 2002). Several brain regions with volume reduction have been reported, e.g. the 
frontal lobe, anterior cingulate cortex, cerebellum, caudate nuclei, corpus callosum, 
amygdala, hippocampus and basal ganglia (Bush, 2011; Bush et al., 1999; Cubillo et 
al., 2010; Kieling, Goncalves, Tannock, & Castellanos, 2008; Krain & Castellanos, 
2006; Plessen et al., 2006; Seidman, Valera, & Makris, 2005; Shaw et al., 2006). In 
children with ADHD, longitudinal studies have shown that maturation of the cortex is 
on average about 3 years delayed compared to controls (Shaw et al., 2007). In 
addition, studies have shown a reduced whole brain cortical thickness in children 
(Shaw et al., 2006) and in several regions in adults (Almeida Montes et al., 2013; 
Makris et al., 2007).  
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Recently, there has a been a transition from models describing a single core deficit in 
ADHD to models positing multiple deficits (Sonuga-Barke, 2003), taking the 
heterogeneity in ADHD into account (Willcutt, Doyle, Nigg, Faraone, & Pennington, 
2005). For example, some models are described as “independent pathways” models 
and suggest that separate neuropsychological subtypes are caused by dysfunctions in 
different pathophysiological substrates (Nigg, Goldsmith, & Sachek, 2004; Sonuga-
Barke, 2005). This was supported by a study (de Zeeuw, Schnack, et al., 2012) where 
differences in neuroanatomical profiles were found across the intelligence range: 
ADHD with lower IQ was more related to neuroanatomical developmental delay, 
whereas ADHD with higher IQ was more associated with more subtle, widespread 
volume reductions.  
The importance of prefrontal cortex in explaining the symptomatology in ADHD is 
essential in most theories of the disorder (F. Levy, 2007). Cognitive control functions, 
or “executive functions”, are closely linked to this region of the brain, and many 
researchers view impairment of those functions as a core deficit of ADHD. For 
example, Barkley (1997) postulated that a core prefrontal cortex associated symptom 
of disinhibition influences several other cognitive functions. Studies using functional 
MRI indicate that EF is dependent on fronto-subcortical-cerebellar networks found to 
be involved in the pathology of ADHD, and research has shown that tasks requiring 
EF are associated with a decreased activation in those areas (Bush, Valera, & 
Seidman, 2005; Cherkasova & Hechtman, 2009).  
There are probably several neurotransmitters involved in the pathology of ADHD. 
Monoamines, and particularly the catecholamines are of interest, especially since 
well-known medical treatments for ADHD (methylphenidate and amphetamine) act 
as agonists for dopamine and noradrenaline by blocking their reuptake in the 
synapses. Dopamine has been described as important for the activation in many brain 
regions, for example the prefrontal cortex (Goldman-Rakic, 1998). The activity of 
dopamine is crucial for motor and cognitive functioning, reward and motivation, and 
a dysfunction in a part of the dopaminergic system could lead to ADHD symptoms. 
For example, Coccaro and colleagues (2007) found that more severe symptoms of 
 24 
ADHD were associated with less dopamine activity in the brain, while another study 
(Fan, Xu, & Hess, 2010) found that mice with deletions of specific dopamine 
receptors exhibited symptoms of ADHD.  Symptoms were reduced with 
amphetamine treatment, which is a treatment of choice in ADHD. However, the 
relationship between ADHD symptoms and neurotransmitter systems is still rather 
poorly understood, and more studies are needed to understand the neurobiological 
underpinnings of ADHD.  
1.5 Genetics of ADHD 
There are different methods to study the genetic factors in ADHD. Quantitative 
genetics, such as family-, adoption- and twin-studies, are used to separate between 
heritable and environmental causes for a given disorder. The development of the field 
of molecular genetics, with linkage and association studies, has made it possible also 
to identify risk genes, and how these genes influence the phenotype.  
Most psychiatric disorders are highly heritable. The estimated mean heritability of 
childhood ADHD has been reported by Faraone and colleagues to be around 76% 
(Faraone et al., 2005). This is much higher than for example some well studied 
somatic diseases such as Parkinson´s disease and breast cancer (Burmeister, McInnis, 
& Zollner, 2008). For adults, the heritability estimates of ADHD have varied 
considerably, probably due to methodological differences between studies. However, 
when using multiple sources of information, the heritability in clinically diagnosed 
ADHD is quite similar in adults and children (Franke et al., 2012).  
Identification of risk genes for this disabling condition may help to predict disease 
progression, improve treatment, and prevent the persistence of ADHD into adulthood 
(Franke et al., 2012). The genetic risk for ADHD is shown to be continuously 
distributed throughout the population, and quantitative genetic studies indicate that 
there are both unique and shared genetic influences on symptoms of hyperactivity-
impulsivity and inattention. ADHD also shares genetic risk factors with traits and 
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clinical syndromes that are commonly co-occuring with ADHD (Asherson & 
Gurling, 2012), and as such, similar genotype may be associated with multiple 
phenotypes. Reversely, multiple genotypes could also be associated with similar 
phenotypes. In addition, genes interact with other genes and different environmental 
factors (Beaver et al., 2007; Li & Lee, 2013; Rosenberg, Pennington, Willcutt, & 
Olson, 2012), further complicating the relationship between phenotype and genes. 
Endophenotypes, that may be defined as “heritable quantitative traits that index an 
individual`s liability to develop or manifest a given disease” (Castellanos & Tannock, 
2002, p. 617), may give a measure closer to the neurobiological underpinnings of the 
disorder than phenotypes, and are also quantifiable in contrast to the dichotomous 
diagnostic categories (Rommelse, 2008). In line with this, research also supports that 
the features characteristic for ADHD is dimensional (Marcus & Barry, 2011) and not 
qualitatively different in cases and controls.   
In linkage studies, data in pedigrees are examined to look for genetic markers that run 
in the family. Association studies can be hypothesis driven (candidate-gene studies) 
or hypothesis free (Genome-Wide Association (GWA) studies). In candidate gene 
studies people with a specific trait or disorder are studied, and it is assessed if certain 
single-locus alleles or genotype frequencies are found more often in the cases than in 
the controls. It is also possible to look at combinations of single-nucleotide 
polymorphisms (SNPs) that are associated statistically- so called haplotypes. Such 
associations may identify other polymorphic sites in the region that could be 
important for disease. Haplotypes may capture the genetic complexity better than 
single SNPs (Nackley et al., 2006), and the studies of haplotypes are still relevant 
although it is now also possible to examine the whole genome with GWA studies. 
Because this is hypothesis free, the whole genome is examined. However, when 
performing such analyses, the risk of type I errors is very high, due to the large 
number of tests conducted. Thus, the criteria to reach statistical significance are very 
strict. A very large sample is therefore required to obtain adequate power to detect 
differences between groups. As such, examination of SNPs or haplotypes within 
candidate genes may be advantageous in studies based on existing hypotheses. 
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The genetic variants involved in adult ADHD may be similar to those involved in 
children, and both common and rare variants are probably implicated in the etiology 
of the disorder. However, some differences have been found in genetics between 
children and adults (Franke et al., 2010), although it is uncertain if this reflects 
different genetic effects across the life span or differences in assessment of ADHD in 
adults and children (Freitag, Rohde, Lempp, & Romanos, 2010).  
Since ADHD symptoms may be related to low levels of dopamine in the prefrontal 
cortex (Sagvolden, Johansen, Aase, & Russell, 2005), many genes that code for 
proteins affecting the dopamine system have been proposed as candidates for ADHD, 
such as COMT (coding for the enzyme Catechol-O-methyl transferase), DRD4 
(coding for Dopamine receptor D4) and SLC6A3 (coding for Sodium-dependent 
dopamine transporter) (Franke et al., 2012). The regulation of dopamine in the 
prefrontal cortex has been shown to be important for EF (Diamond, Ciaramitaro, 
Donner, Djali, & Robinson, 1994), often considered to be the essential function that 
is compromised in ADHD (Barkley, 2012; Brown, 2006). The COMT gene may be 
especially relevant in studies of ADHD, as it encodes a key enzyme in the catabolism 
of dopamine in the prefrontal cortex. This is in contrast to subcortical brain regions 
where the dopamine transporter primarily is responsible for the metabolism of 
dopamine (Floresco, West, Ash, Moore, & Grace, 2003) (Figure 1). 
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Figure 1. Synthesis and degradation of dopamine. The L-transporter transports the amino acid tyrosine across 
the cell membrane, and via dopa, tyrosine is converted to dopamine (DA). Before it is released to the synaptic 
cleft, it is stored in synaptic vesicles. DA can bind to presynaptic autoreceptors, or five different postsynaptic 
receptors (D1-5). D2 and D3 are also found presynaptically. In the synaptic cleft, dopamine is degraded by 
COMT or by the reuptake by a dopamine transporter (DAT) in the presynapse. There, it is recycled or degraded 
by monoamine oxidase (MAO). COMT is mainly found postsynaptically, but has also been detected 
intracellularly and in glia cells.  
 
In a study of rats, it was estimated that the COMT enzyme accounted for more than 
60% of the degradation of dopamine in the prefrontal cortex, in contrast to less than 
15% in the striatum (Karoum, Chrapusta, & Egan, 1994). In line with this, studies 
have shown a relationship between the COMT gene and EF (Favaro et al., 2013), 
such as impulsivity (Soeiro-De-Souza, Stanford, Bio, Machado-Vieira, & Moreno, 
2013) and set shifting (Tunbridge, Bannerman, Sharp, & Harrison, 2004). Most 
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studies on the COMT gene and ADHD have examined the COMT Val158Met 
polymorphism, where the Val allele has been suggested to lead to faster degradation 
of prefrontal dopamine than the Met variant (Lachman et al., 1996). The research 
concerning this polymorphism has been inconclusive, probably due to problems such 
as small samples or methodological differences. The inconclusive results could also 
be related to the fact that linkage disequilibrium in different populations varies 
between Val158Met and other nearby SNPs, which may lead to different results in 
different populations. Nackley and colleagues (Nackley et al., 2006) suggested that 
COMT haplotypes modulate the expression of the protein by altering the secondary 
structure of mRNA and that the Val158Met and other SNPs interact to determine the 
functional expression of the gene. The study of COMT haplotypes therefore may give 
more information about the functional properties of this gene than the Val158Met 
polymorphism alone. 
However, so far, genetic studies of ADHD have been inconclusive, and the effects 
have generally been small. In large-scale attempts with Genome-Wide Association 
(GWA) studies, no genes have reached the criteria for significance. This may be due 
to the polygenic and heterogeneous nature of the disorder, methodological differences 
and random variations. However, GWA studies have yielded significant results in 
other psychiatric disorders, and this may also happen in the field of ADHD when 
even larger samples are examined. Despite this, other, more theory based methods, 
such as the study of haplotypes in relation to different clinical measures, are still 
relevant in the field of neuropsychiatric genetics.  
1.6 Executive functioning (EF) in ADHD 
1.6.1 Executive functioning 
The word “executive” is derived from latin “executio”, meaning to perform or fulfill. 
In line with this, the concept of EF has been defined as “general-purpose control 
mechanisms that modulate the operation of various cognitive sub processes and 
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thereby regulate the dynamics of human cognition” (Miyake et al., 2000 p. 50). 
However, many different definitions and theories have been presented aiming to 
describe the nature of this complex concept. Barkley (2012) claimed that 40 to 50 
different definitions of EF have been published. There are also different opinions 
with regard to how broadly this concept should be defined. This has implications for 
the understanding of EF in neuropsychiatric disorders. Several questions and 
challenges exist concerning our understanding of EF in ADHD, some of which are 
described below.  
1.6.2 Is ADHD a disorder of executive dysfunction? 
Impairment of EF has been described as a core deficit in ADHD (Barkley, 2010; 
Castellanos, Sonuga-Barke, Milham, & Tannock, 2006). EF is often assessed by 
neuropsychological tests. Such tests are widely used in studies and assessment of 
neuropsychiatric disorders. However, there is often considerable overlap between 
controls and patients in performance on neuropsychological tests designed to measure 
EF. In ADHD groups, the variance in performance is generally higher than in 
controls (Nigg, Willcutt, Doyle, & Sonuga-Barke, 2005), and far from all individuals 
with ADHD show impairment on tests intended to measure EF (Willcutt et al., 2005). 
It is possible that this reflects the heterogeneity of ADHD, where several factors may 
constitute pathways to ADHD (Nigg et al., 2005; Wahlstedt, Thorell, & Bohlin, 
2009). As such, those displaying EF deficit on neuropsychological tests may 
represent a distinct subgroup separate from subgroups, possibly with a different 
pathophysiology. This was supported by a study indicating that neurocognitive 
subtyping is possible based on information about cognitive control, temporal 
processing or reward sensitivity (de Zeeuw, Weusten, van Dijk, van Belle, & 
Durston, 2012). In line with this, Nigg and colleagues (2005) have proposed that the 
assumption of etiologic homogeneity has had a negative impact on ADHD research 
and suggested to separate between ADHD with and without EFD. They argued that 
this would stimulate research validating subtypes of ADHD, lead to the development 
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of more sophisticated causal models, and that this in longer term could provide 
clinicians with better ways to tailor and target treatments.  
However, it has also been argued that neuropsychological tests do not capture all EF 
problems experienced by patients with ADHD because the test-situation in itself is 
very structured and far from the daily life where the patients often experience and 
describe such problems (Barkley & Fischer, 2011). It has been shown that a patient 
may pass lab-based EF tests despite having severe problems with EF in daily life 
(Saver & Damasio, 1991). Toplak, West & Stanovich (2013) suggested that although 
intended to index the same underlying mental construct of EF, rating scales and 
performance based measures actually measure different underlying mental constructs. 
They also cited empirical work that only has demonstrated small to modest 
correlations between such measures. This supports the notion that the subgroup with 
test-defined EFD is a qualitatively different group with specific features.  
1.6.3 The unity and diversity of executive functioning 
Today, it is widely acknowledged that the structure of EF in adulthood is 
characterized by both unity and diversity. Originally, this was proposed by Teuber 
(1972). An important contribution to this knowledge is the research by Miyake et al. 
(2000), who attempted to examine the underlying structure of EF by examining three 
basic, important parts of EF  (inhibition, updating and set shifting) proposed to be 
involved in more complex functions, such as planning. They used latent variable 
analyses, where the latent variables represented purer measures of the target ability 
free from measurement error, and concluded that both “unity and diversity” 
characterize EF.  The latent variable is defined as an ability that is influencing 
performance on a set of tests. The selected tests should therefore measure a common 
underlying construct, in addition to measuring different nonexecutive variance. 
Statistical extraction is used to tap the target construct that is implicated in all tests. In 
the study by Miyake et al. (2000), the “unity” was confirmed in that different aspects 
of EF correlated with one another and as such probably tapped some common 
underlying ability. However, separability was also shown, supporting the notion that 
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EF in addition is characterized by diversity. Miyake & Friedman (2012) referred to 
several studies (Friedman et al., 2006; Friedman, Miyake, Robinson, & Hewitt, 2011; 
Rose, Feldman, & Jankowski, 2011; Vaughan & Giovanello, 2010) that support this 
view of EF. In addition, it is supported by studies showing that both common and 
unique brain areas are involved in the three functions studied by Miyake et al. 
(Collette et al., 2005). At a clinical level, specific EFs are probably more closely 
related to certain disorders or symptoms than others. For example, Friedman et al. 
(2008) have shown that inhibition is more closely related to externalizing behavior 
and attention problems in the classroom than updating and shifting (Friedman et al., 
2007; Young et al., 2009). Their study also suggested that individual differences in 
EF, measured as latent variables, are nearly entirely genetic, and probably more 
heritable than IQ (Friedman et al., 2008). The results indicated that the unity of EF is 
due to impact of a common factor of EF with 99% heritability. The genetic influence 
was also high for specific functions with unique genetic influence to shifting (42%) 
and updating (56%), but not for inhibition. This highlights that genes are influencing 
EF at multiple levels, and that latent variables may be useful to distinguish these 
influences.   
 
1.6.4 The task impurity problem 
The assessment of EF is challenging because the tests are complex and also involve 
other, more basic functions in addition to the EFs. For example, Willcutt, Doyle, 
Nigg, Faraone & Pennington (2005) argued that it may be difficult to know whether a 
weak result on a test is really due to a weakness in the construct for which the task is 
intended to measure, and that future studies should try to isolate specific parameters 
of interest. They suggested that this may be done with careful analyses of the task and 
by developing suitable within-task and between-task controls. This so called “task 
impurity problem” (Miyake et al., 2000) complicates the interpretation of studies 
based on single tasks, as nonexecutive variance may be involved and this makes it 
unclear to what extent positive and null results reflect EF (Friedman et al., 2008). 
Miyake & Friedman (2012) proposed that any score on an EF task includes 
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systematic variance attributable to non-EF processes like color processing and 
articulation speed. They described this measurement error of systematic non-EF 
variance as substantial, and stated that this makes it difficult to measure the clean EF 
variance of interest. As a solution to the problem, they used the before mentioned 
latent-variable approach where they “extracted” what is common between the tasks, 
producing a more “pure” latent variable as measure of EF. Correlations between the 
common EF factor (latent variable) and perceptual speed/IQ were far from 1.0, 
suggesting that the EF factor not only reflects those functions, but goes beyond 
perceptual speed and IQ (Friedman et al., 2008). In addition to latent variable 
analyses, it is possible to control for the basic functions, using measures of more 
basic functioning as covariates. Then, there is no need to include several tests 
measuring the same construct. Some tests, such as tests included in the D-KEFS, 
comprise conditions that assess basic functioning, which makes it possible to subtract 
the lower level functions from the higher-level functions. The inclusion of such 
“pure” scores in the test manual makes D-KEFS applicable and useful also in a 
clinical setting. Since D-KEFS is standardized and validated on a relatively large 
sample, and is widely used also in a clinical setting, the contrast scores from D-KEFS 
may be suitable in studies of “pure measures” of EF.  
Several of the D-KEFS tests are measuring set shifting, defined as the ability to move 
back and forth between multiple tasks, operations and mental sets (Miyake et al., 
2000). This function has been described as a potential endophenotype for ADHD 
(Boonstra et al., 2008), i.e. a measure that lies between the geno- and phenotype. 
However, although set shifting has been widely studied in ADHD (Barkley, Murphy, 
& Fischer, 2008; Piek, Dyck, Francis, & Conwell, 2007), the results have been 
inconclusive. This may be due to ceiling effects, different tests and methodologies 
used and not controlling for basic functions. One of the tests measuring this function 
in D-KEFS is the Color-Word Interference Test (CWIT), which is a further 
development of the traditional Stroop-test. The Stroop-test is widely used in ADHD 
research, as it measures inhibition, which is suggested to be a core function 
implicated in ADHD (Barkley, 2012). However, the newer version of this test 
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including set shifting may also be relevant in ADHD since it probably reduces some 
of the earlier problems related to the assessment of this function in ADHD.  
Although the influence of basic functioning may be the greatest challenge when 
assessing EF, other EFs than the target function could be involved in the task as well. 
For example, working memory may be implicated in several EF tasks, even if this is 
not the targeted function. In line with this, Ravizza & Ciranni (2002) pointed to the 
relationship between set shifting and working memory. To control for other EFs 
could be important to obtain a “pure” measure of the targeted function, but may be 
problematic. For example, in ADHD, working memory may be a part of the disorder 
itself, and controlling for this could therefore lead to removing variance that is due to 
ADHD instead of the targeted function.  
The same challenge concerns the relationship between EF, ADHD and IQ. The 
influence of IQ on EF tests and ADHD symptoms has been found in several studies 
(e.g. Adolfsdottir, Sorensen, & Lundervold, 2008; Tillman, Bohlin, Sorensen, & 
Lundervold, 2009). Dennis et al. (2009) argued that even though IQ accounts for all 
the variance in a measure of cognitive performance, it does not explain the 
relationship between IQ and EF, as there may be a common latent variable that 
accounts for both results, such as ADHD. This is supported by Rommelse et al. 
(2008), who found independent familial segregation of EF and intelligence measures 
in families with ADHD.  
 
1.6.5 Functional outcomes of adult ADHD and executive function 
deficit (EFD) 
Adults with ADHD are often impaired in a wide range of functions (Biederman, 
Faraone, et al., 2006; Gjervan et al., 2012; Halmoy et al., 2009). In addition, they may 
have a history of school failure, struggle with comorbid disorders, such as antisocial, 
depressive and anxiety disorders, and are often involved in traffic accidents. In a 
study from our group, 24% of the patients were in work, compared to 79% in the 
population-based control group (Halmoy et al., 2009). In USA, the work loss cost of 
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adults with ADHD and adult family members in the year 2000 was estimated to be 
$3.7 billion (Birnbaum et al., 2005). Even among workers, ADHD on average leads 
to around 4-5% reduction in work performance (Kessler, Lane, Stang, & Van Brunt, 
2009). Halmøy et al. (2009) found that substance abuse, combined subtype of ADHD 
and a history of depression/anxiety were correlated with being out of work, while 
medical treatment in childhood was the strongest predictor for being employed in 
adulthood. Current medical treatment for ADHD was also positively correlated with 
employment. Despite this, only a small minority of workers in a recent survey 
undertaken by the World Health Organization was treated for ADHD (de Graaf et al., 
2008). To identify possible risk factors for negative functional outcome within the 
heterogeneous group of individuals with ADHD may be of importance for treatment 
and interventions. One such risk factor may be EFD. As discussed earlier, some 
researchers argue that ADHD is a disorder of EF dysfunction, while others suggest 
that only a subgroup within ADHD have such problems. Regardless what perspective 
is taken concerning this issue, the group with test defined EFD may be a distinct 
subgroup characterized by different functional outcomes than the group without EFD. 
For example, research indicates that deficits in a test-defined EFD-group are 
important for a range of daily-life activities (Miller, Nevado-Montenegro, & 
Hinshaw, 2012; Nigg et al., 2005), and research is therefore needed to characterize 
the deficits and functional outcomes in this subgroup.  
1.7 Heterogeneity in ADHD 
As already mentioned, studies suggest that ADHD is a complex, heterogeneous 
condition, probably consisting of different subgroups. The multifactorial nature of the 
disorder points to a high degree of aetiological heterogeneity, probably with a 
different degree of environmental and genetic contributing factors in different 
individuals. As Nigg (2005) argued, the search for homogeneous explanations in 
ADHD research may be misleading. At a basic neurobiological level, separate 
mechanisms may be implicated in different subgroups of patients, while this may be 
reflected in separate neuropsychological profiles at another level. At a clinical level, 
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the heterogeneity could be reflected in different presentations of the disorder, which 
may be associated with certain functional outcomes. The name of the main study: 
”ADHD in Norwegian adults: From clinical characterization to molecular 
mechanisms” reflects a translational perspective and highlights the importance of 
investigating ADHD at different levels, from more basic mechanisms, to long term 
functional outcome. The studies included in this thesis also reflect this perspective 
through focusing on a range of issues concerning EF in ADHD, spanning from basic 
mechanisms to occupational outcome.  
1.8 The present study 
1.8.1 Aims 
The aims of this thesis were to apply translational research and involve information at 
multiple levels to improve our understanding of ADHD. Specifically, we aimed to: 1) 
investigate if COMT haplotypes, suggested to lead to different dopamine levels in the 
prefrontal cortex, are related to symptom dimensions of ADHD, 2) investigate a 
“pure” measure of set shifting in ADHD patients using the CWIT from the D-KEFS, 
3) examine functional outcomes of psychometrically defined EFD in patients with 
ADHD. 
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2. Materials and method 
2.1 Participants 
All participants in the three studies were enrolled in the main project: “ADHD in 
Norwegian Adults: From clinical characterization to molecular mechanisms”. When 
the third study was conducted, 800 adults with ADHD diagnosed according to the 
DSM-IV criteria and 909 control persons had been included in the project. The 
recruitment of patients and controls is illustrated in figure 2.  
 
 
 
Figure 2: The cumulative recruitment in the period from 2004-2014 is illustrated for patients and controls in the 
main project, and for the neuropsychological tested patients and controls. The arrows indicate end of inclusion 
for the different studies.  
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Patients (>18 years old) were recruited through clinicians (mainly psychiatrists) 
nationwide or from a national registry of adults diagnosed in Norway from 1997 to 
May 2005.  
This national registry was based on a diagnostic assessment conducted by three to 
five clinicians with specialized experience in diagnosing ADHD in children and 
adults (mainly psychiatrists and neuropsychologists) in three national expert 
committees of ADHD/hyperkinetic disorder. The background for establishing the 
teams was that prescription of central stimulants was legally restricted for adults in 
Norway until 1997. However, it was possible to receive this treatment from October 
1997 to May 2005 if the committees approved the diagnostic evaluation. Thus, the 
teams ensured that the diagnostic practice was standardised across the country. 
Although ICD-10 is the official diagnostic system in Norway, allowance was made 
for the diagnosis of the inattentive subtype in DSM-IV. In addition, presence of 
comorbid disorders was also allowed if the criteria for ADHD were fulfilled and 
present before the comorbid disorders appearance. Psychiatrists, hospital doctors or 
general practitioners referred the patients to the committees. The referral procedure 
required patient records, describing current symptoms and functioning, collateral 
information about childhood behaviour and functioning and results from psychiatric 
and physical examinations. Through reviewing the patients’ records, a confirmation 
or disproval of the diagnosis of ADHD was made, and use of treatment with central 
stimulants was recommended or not based on the diagnosis and contra-indications for 
such treatment.  
Although the data from the committees were not designed as a patient registry, it 
represents a national cohort of adult ADHD patients. More than 5000 patients were 
handled, of which nearly 70% (N=3397) were recommended for treatment. Between 
2005 and 2007, 1700 invitation letters were sent to adults with ADHD included in the 
lists from the teams, mainly targeting individuals referred after the year 2000.  
National Guidelines for Diagnosing Lifespan ADHD were effectuated in May 2005 
by the Norwegian Health Authorities, and from that point of time, diagnostics of 
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ADHD was done by specialists in psychiatry without the mandatory evaluation by the 
expert committees. Psychologists and psychiatrists nation-wide were therefore also 
invited to recruit adults with ADHD who were formally diagnosed according to the 
national guidelines based on the criteria used by the expert teams, but without the 
evaluation of the teams.  
Criteria for inclusion in the project were age 18 years or older at time of inclusion in 
addition to a diagnosis of ADHD or Hyperkinetic Disorder (according to the DSM-IV 
or ICD-10 criteria) received in adulthood or childhood prior to the inclusion in the 
project. 
The Medical Birth Registry of Norway (MBRN) was used to recruit the control 
group. This registry includes individuals born in Norway after January 1st 1967. 
Invitation letters were sent to a randomly selected nation-wide sample of 2963 
individuals between 18-40 years. In addition, a subsample was recruited by means of 
local advertisements (N=189).  
All participants were asked to complete a set of questionnaires and donate a sample 
of blood or saliva for DNA-extraction. Persons from the main study living in or 
around Bergen were also randomly selected and invited to take part in a psychiatric 
interview (performed by psychiatrist) and a neuropsychological examination 
(performed by a trained test technician).    
In the first paper, 435 diagnosed ADHD-patients and 383 controls with self-report 
data and saliva/blood samples were included. In the second paper, 60 patients and 60 
controls were included, while 79 patients and 77 controls were included in the third 
paper. In the two last studies, the participants went through neuropsychological 
testing and a psychiatric interview.  
The recruitment procedure is illustrated in figure 3. 
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Figure 3: Recruitment protocol 
2.2 Assessment 
2.2.1 Questionnaires 
Screening questions  
The participants answered 31 questions concerning socio-demographic and clinical 
factors. Information about life-time comorbidities was collected by asking the 
participants if they have or have had other disorders, including bipolar disorder, 
significant depression/anxiety, reading/writing difficulties, etc.  The patients also 
were asked to give a form to their doctor with questions about medical treatment and 
diagnosis. 
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Self-report questionnaires 
The Wender Utah Rating Scale (WURS: Ward, Wender, & Reimherr, 1993) was used 
to measure ADHD symptoms in childhood. This questionnaire has been validated and 
contains 25 questions that should be answered on a 5-point Likert scale. The Adult 
ADHD Self Report Scale (ASRS: Kessler et al., 2005) was used to assess current 
ADHD symptoms. This is the World Health Organization`s rating scale for adult 
ADHD, and measures ADHD symptoms on a 5-point Likert scale. The questionnaire 
is split in two, where the first 9 questions assess inattention symptoms, and the last 9 
cover symptoms of hyperactivity and impulsivity. Although those questionnaires 
were not officially validated in Norway, they have been extensively used both in the 
clinic and in research (K. Rasmussen, Almvik, & Levander, 2001). The version of 
ASRS included in this project was also used by the Expert Committees of 
Hyperkinetic Disorder/ADHD, and was originally translated and retranslated by an 
Enghlish-native employee of the Norwegian Department of Health and Social 
Welfare. It was later evaluated by 4 experienced psychiatrists in our project group. 
(See Appendix for the questionnaires used in the present studies).  
2.2.2 Genotyping 
DNA was either extracted from saliva using the Oragene DNA Self-Collection Kit 
from DNAGenotek (DNA Genotek, Inc., Ontario, Canada) at the HUNT biobank 
(Levanger, Norway), or from whole blood. DNA from both cases and controls were 
mixed on 90-well plates with two blank samples and at least two internal controls on 
each plate. Genotyping of SNPs (rs4680, rs4818) was done using the MassARRAY 
iPLEX System (SEQUENOM, Inc., San Diego, CA) and the TaqMan allelic 
discrimination assay (rs6269, rs4633). The concordance rate for total genotyping was 
100%, and no SNP deviated from Hardy-Weinberg equilibrium.  
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2.2.3 Neuropsychological tests 
Wechsler Abbreviated Scale of Intelligence 
Two subtests (Matrix Reasoning and Vocabulary) from the Wechsler Abbreviated 
Scale of Intelligence (WASI) were used to get an estimate of IQ according to the 
norms presented in the test manual (Wechsler, 1999) 
Tests from D-KEFS 
D-KEFS is the first battery of tests designed to exclusively measure EF which is co-
normed on a representative and large sample (Homack, Lee, & Riccio, 2005). It 
includes tests assessing several functions, such as flexibility of thinking, impulse 
control, planning and inhibition. D-KEFS also includes contrast measures, where the 
influence of basic functions is subtracted from the targeted measure. The battery 
comprises nine tests that may be administered together or separately, and provides a 
standardized examination of adults and children from 8 to 89 years.  
Four tests from the D-KEFS measuring functions that have been reported affected in 
ADHD (Boonstra, Oosterlaan, Sergeant, & Buitelaar, 2005; Halleland, Haavik, & 
Lundervold, 2012; Wodka et al., 2008) were used in the third paper, while the Colour 
Word Interference Test (CWIT) was used in the second paper. The chosen tests are 
all traditional tests that have been further developed and modified in D-KEFS.  
Trail Making Test 
The fourth condition was used as a measure of working memory function and visual 
set shifting and requires the participant to draw a line between letter and number 
sequences, measuring number of seconds completing the test.  
Word Fluency Test 
The first condition, where the participants are asked to search for words beginning on 
a specific letter, was selected as a measure of the ability of word-generation. The 
fourth and fifth conditions measure different aspects of verbal category switching 
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(number of correct responses and switching accuracy). The number of correct 
responses, correct switches and switching accuracy are measured.   
Colour Word Interference Test (CWIT) 
The third condition of CWIT was used as a measure of inhibition. The task in this 
condition is to inhibit reading words denoting colours while naming the incongruent 
colour of the word. In the fourth condition, the test person is asked to alternate 
between inhibiting an automatic response of reading (as in the third condition) and 
reading the colour word if the word is framed. This condition therefore requires both 
inhibition and set shifting abilities. The outcome measure is time to complete each 
condition.  
Tower Test 
In this test, the participant is instructed to build a tower while following certain rules. 
The primary score is the “achievement score”, which is based on if the tower is 
correct or not, number of moves and time. This score measures working memory 
function and the ability to plan ahead.  
Paced Auditory Serial Addition Task 
Paced Auditory Serial Addition Task (PASAT: Gronwall, 1977) was used to measure 
working memory. Participants were presented (auditory) a number between 1 and 9 
every 3 seconds, and should always add the two last numbers. Working memory was 
defined as number of correct responses given on this task.  
2.2.4 Psychiatric interview 
In the subgroup undergoing neuropsychological assessment, the semi-structured 
diagnostic interview MINI Plus version 5.0.0 (Sheehan et al., 1998) was used by the 
psychiatrists to assess psychiatric comorbidity (current substance abuse/dependence 
and current depressive/manic episode in study 2).  
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2.3 Statistics 
Different versions of SPSS were used to perform statistical analyses in the three studies. A 
p-value of 0.05 was used when the basic assumptions (equality of covariance, equality of 
error variance etc.) were fulfilled. Analysis of variance (ANOVA), and χ2 tests were used to 
compare clinical and demographical data among the groups in all the articles. In the first 
article, single marker tests and allele frequencies were calculated with use of the PuTTY link 
(PLINK) software. PLINK and the Statistical Package for the Social Sciences (SPSS) 
software were used to perform linear regression analyses, while WHAP and PLINK was 
used to perform haplotype analyses. In the second study, factorial multivariate analysis of 
covariance (MANCOVA), ANOVA and analysis of covariance (ANCOVA) were used to 
investigate differences between groups on the neuropsychological measures. Working 
memory and IQ were added as covariates for significant results. For residual scores, 
hierarchical and standard regression analyses were used. In the third study, ANOVA and χ2 
(Pearson) analyses were used to investigate differences between groups in functional 
impairment. ANCOVAs and logistic regression analyses were performed for significant 
results.   
2.4 Ethics 
All participants filled in a written informed consent. The project was approved by the 
Regional Committee for Medical Research Ethics of Western Norway IRB # 3 (FWA 
00009490, IRB 00001872) and the Norwegian Data Inspectorate. The participants 
received NOK 250 for returning blood or saliva samples and questionnaires, and 
additional NOK 500 if interviewed and tested.  
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3. Results 
3.1 Paper 1 
In this study, we investigated the association between COMT haplotypes and ADHD 
symptoms. We found that all markers (rs6269, rs4633, rs4818, rs4680) showed a 
trend for association with the hyperactivity/impulsivity scale, peaking at marker 
rs6269 (p=0.007). The risk allele of rs6269 was through haplotype analysis found to 
tag the proposed high COMT-activity haplotype (P=0.01) that in our sample was 
associated with the highest hyperactivity/impulsivity score. In addition, for the 
proposed mid and low activity haplotypes, an associated stepwise decreased 
hyperactivity/impulsivity score was found. No association was found for the 
questions addressing impulsivity when investigated separately. Analysis stratified for 
use of medication showed that the haplotype association primarily was caused by the 
subgroup on medication.  
3.2 Paper 2 
This study examined if adult ADHD patients showed difficulties of set shifting and 
inhibition using the CWIT from the D-KEFS. A group of adults with ADHD obtained 
significantly lower scores than population derived controls on both primary summary 
(P<0.001) and contrast measures (P=0.004) of set shifting. In addition, similar 
results were found when using an alternative way to calculate the contrast scores 
based on raw scores, with use of residuals. Differences between the groups were 
statistically significant after controlling for intellectual function and working memory 
(P=0.003). No significant differences were observed on any measure of inhibition. 
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3.3 Paper 3 
In this paper, we examined if the group with EFD displayed distinct features. In the 
ADHD group, 24.3% showed EFD, while this was found in 10.8% of the control 
group. When controlling for age, this difference was not statistically significant 
(p=0.098). The ADHD-group with EFD was characterized by a significantly higher 
frequency of unemployment, more reading and writing problems, lower IQ and 
higher self-reported score of ADHD-symptoms in childhood as measured with the 
Wender Utah Rating Scale (WURS) than the ADHD-group without such impairment. 
In the ADHD-group with EFD, only 6.7% were employed, while 52.1% were 
employed in the ADHD group without EFD. This difference was statistically 
significant also after controlling for age and reading and writing problems. In 
contrast, none of the participants in the control group with EFD were unemployed. In 
addition, there was a significant difference between the groups on the CWIT in 
frequency of impairment. This difference was only found for the inhibition/set 
shifting condition. In the ADHD-group, 28.4 % showed impairment on this condition, 
while this was true for only 6.8% in the control group (p<0.001). 
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4. Discussion 
4.1 Main findings 
The thesis includes themes ranging from basic mechanisms in ADHD to functional 
difficulties and occupational outcome. Despite the wide range of topics, many 
questions concerning the nature of ADHD are relevant to the findings in all three 
papers. In the following, some topics related to the understanding of ADHD are 
discussed in light of the results from the studies included in this thesis.  
4.1.1 A dimensional approach to ADHD 
In the study of COMT haplotypes, ADHD symptoms were defined along a continuum 
from no symptoms in some of the controls to severe symptoms in some of the adults 
with ADHD. According to this perspective, the symptoms of ADHD are not limited 
to patients, but are present, albeit to a lesser degree, also in the general population. 
Instead of using distinct categories, we examined quantitative symptoms as measured 
by the ASRS, controlling for group status. The continuum approach may be closer to 
the nature of many psychiatric disorders than a categorical classification (Levy, Hay, 
McStephan, Wood, & Waldman, 1997) and also increases statistical power by 
retaining the variance. This was supported by our study, where a tendency for 
association was found between the tested SNPs and the hyperactivity/impulsivity 
dimension of the ASRS in the whole sample, but to a lesser extent when using ADHD 
as a categorical variable. Twin studies, indicating that similar set of genes are 
involved in the clinical syndrome of ADHD and the subclinical form of the disorder 
are in line with this finding (F. Levy, Hay, McStephen, Wood, & Waldman, 1997). 
Faraone (2000) argued that many of these genes are associated with the development 
of ADHD. Those with only a few of these genetic variants will be asymptomatic, 
while those in between will have some symptoms, but not enough to meet the 
threshold for the disorder.  The relationship between genes and symptoms will also be 
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mediated by epigenetics and the interaction between genes and environment.  
 
Somewhat counterintuitive to the dimensional perspective, we found a symptom 
specific effect of COMT; the association between the ASRS and the COMT 
haplotypes was only statistically significant for the hyperactivity/impulsivity scale. 
This is in line with results from studies indicating that although similar genes are 
associated with both the hyperactivity/impulsivity dimension and the inattentive 
dimension, there are some symptom specific effects (McLoughlin, Ronald, Kuntsi, 
Asherson, & Plomin, 2007). In addition, it has been suggested that EF problems may 
be related only to the combined or hyperactive/impulsive subtypes (Barkley, 1997). 
This supports that COMT variants may be related to the hyperactivity dimension of 
ADHD through influencing EF, and is in line with studies showing that COMT are 
related to EF. The different results for the groups with and without medications also 
suggest that there are subgroups within the diagnostic group. Nevertheless, a 
dimensional approach may still be the best way to investigate heterogeneity in 
ADHD, as subgroups do not necessarily follow conventional diagnostic borders.  
4.1.2 Heterogeneity in ADHD and regulation of dopamine in 
prefrontal cortex 
The finding that COMT haplotypes were related to symptoms of hyperactivity 
support the hypothesis that low levels of dopamine in the prefrontal cortex are 
implicated in ADHD (Sagvolden et al., 2005; Solanto, 2002). This hypothesis has 
also been supported by studies showing that methylphenidate reduces symptoms of 
hyperactivity (Gorman, Klorman, Thatcher, & Borgstedt, 2006). It is also in 
accordance with the finding of an association between the high activity Val allele of 
the Val158Met polymorphism and ADHD (Kereszturi et al., 2008), and associated 
problems, such as conduct disorder, aggression (Caspi et al., 2008) and impaired 
performance on cognitive tasks (Egan et al., 2001). However, results from different 
studies are conflicting, with some studies also showing association between ADHD 
symptoms and the low activity Met allele (DeYoung et al., 2010; Nikolac Perkovic et 
al., 2013; Palmason et al., 2010). Faraone (2000) has argued that if ADHD is not a 
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unitary disorder, but consists of several disorders with different non-genetic and 
genetic aetiologies, one should expect small genetic effects, and inconsistent patterns 
of replication. This was supported by our study, as the association between COMT 
haplotypes and symptoms of hyperactivity was only found in the ADHD group on 
medication. The participants in the non-medicated group may be non-responders who 
represent a qualitatively different group with another aetiology than the group on 
medication. Such differences may be due to several factors, such as a different 
genetic background, gender effects, gene-gene interactions and gene-environment 
interactions influencing the regulation of dopamine in the prefrontal cortex (Nobile et 
al., 2010). We have recently found that the non-responders have significantly 
different DAT1 genotypes than the responders, supporting this hypothesis (Hegvik et 
al., personal communication). As such, it is possible that different COMT variants 
may be beneficial for different individuals due to unknown factors influencing the 
total level of dopamine in prefrontal cortex. The theory of the inverted u-curve, where 
either too little or too much dopamine is leading to impaired performance, is in 
accordance with this finding. This was supported by a study where participants with 
ADHD and the low activity met/met COMT genotype showed an increased risk for 
adverse response to amphetamine compared to the val/val homozygotes (Mattay et 
al., 2003). Another study also found that those with the high activity val/val genotype 
showed a better response to treatment with methylphenidate than the val/met or the 
met/met genotype (Cheon, Jun, & Cho, 2008). Interestingly, using functional 
imaging, Cheon and colleagues (2008) found that genotype by drug interaction was 
restricted to the prefrontal cortex, which supports the involvement of COMT in 
prefrontal functioning. However, although impulsivity is shown to decrease with 
increasing level of dopamine in prefrontal cortex (Kayser, Allen, Navarro-Cebrian, 
Mitchell, & Fields, 2012), we found no specific association between items on the 
ASRS aimed to measure impulsivity and the COMT haplotypes. Further studies are 
needed to gain knowledge about the complex relationship between COMT genotypes, 
regulation of dopamine and symptoms of ADHD. In addition to factors influencing 
the level of dopamine in prefrontal cortex, several other factors are expected to 
contribute to the development of this complex disorder. Sun and colleagues (Sun, 
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Yuan, Shen, Xiong, & Wu, 2014) argued that information about gene-gene and gene-
environment interactions should be included in future studies of the COMT gene. To 
gain more knowledge about the relationship between geno- and phenotype, 
biologically based phenotypes lying between genes and behaviour (endophenotypes), 
such as neuropsychological measures of EF, may also be useful (Doyle et al., 2005; 
Gau & Shang, 2010; Goos, Crosbie, Payne, & Schachar, 2009). Doyle et al. (Doyle et 
al., 2005) suggested that endophenotypes might be especially important for the 
understanding of the aetiology in complex disorders where different environmental 
factors and several genes influence the phenotype. Because the endophenotype is 
expected to be less genetically complex than the underlying disorder, it may lead to 
stronger statistical power that makes it possible to detect the effects of different 
genes.  
4.1.3 Is it possible to obtain “pure” measures of EF? 
In the second study, we found a difference in set shifting between the ADHD- and 
control group, also after controlling for covariates, which indicates that set shifting 
difficulties may signal a potential endophenotype in ADHD. However, it is an on-
going discussion whether it makes sense to split EF into subfunctions, a procedure 
that is commonly used by clinicians and neuropsychological researchers. Rabbitt 
(1997) has argued that trying to measure specific processes through isolating one 
variable violates the central assumption of the nature of EF, as this involves the 
ability to simultaneous manage several different functional processes. Despite this, it 
could also be that EF includes specific functions partly unrelated to other functions. 
The research by Miyake and colleagues (2000), showing both unity and diversity in 
EF, indicates that it makes sense to study EF at a more general level, with summary 
scores from several tests, but also at a more specific level to obtain “pure” measures.  
When using standard clinical tests, it may be difficult to obtain such “pure measures”. 
In the second study, we therefore included tests from D-KEFS, which makes it 
possible to control for basic functions. We also controlled for IQ and working 
memory.  However, we cannot conclude that we have controlled for all relevant 
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functions. In addition, there may be better methods to control for basic functioning 
than using the D-KEFS contrast measures. Since Crawford et al. (2008) argued that 
most of the variance in the contrast scores is measurement error variance, and 
therefore recommended not to use these measures, we also included an alternative 
method of calculation of “pure measures” based on raw scores. We obtained similar 
results, which supports the validity of the D-KEFS contrast measures, at least for the 
set shifting condition from the CWIT that was used in the present study.  
In addition to the challenge of controlling for basic measures, IQ is often controlled 
for in studies of ADHD and EF. However, it may be impossible to separate IQ from 
the effects of the studied function, because when controlling for IQ, we probably also 
control for a part of the disorder itself (Dennis et al., 2009). This was supported by a 
study showing genetic overlap between IQ levels and ADHD (Kuntsi et al., 2004). 
Dennis et al. (2009) further argued that IQ often does not meet the criteria for being a 
covariate and that the practice of controlling for IQ has lead to overcorrected, 
anomalous and counterintuitive findings. We therefore chose to present results both 
with and without controlling for IQ in the second paper. The similar results for set 
shifting with and without control for IQ are in line with previous studies, showing a 
minimal influence of IQ on set shifting (Friedman et al., 2006).  
The problem of what to control for, and when, is an on-going debate in 
neuropsychological research. To reduce this problem, the method of latent variable 
analyses used by Miyake et al. has been used to extract more pure measures from 
several tests, and should be considered when designing future studies of set shifting 
and other EFs in ADHD. This is probably also relevant when relating EF to genetic 
information, as this gives an opportunity to separate the different levels (general 
versus specific) of genetic influence on EF, which is impossible when using only one, 
complex EF test (Friedman et al., 2008). However, if not choosing proper tests, for 
example if similar basic conditions are affecting the tests used to extract the pure 
measure, it will still be a problem to obtain a pure measure of EF.  
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In addition, Miyake et al. (2000) argued that a test could measure different functions 
depending on the experience the person has with a test or similar tasks. If a person is 
familiar with the present task, the test would no longer tap EF.  One possible 
hypothesis is thus that the ADHD-group in our study has lower scores on the set 
shifting condition because they get less effect of training from the previous condition 
than the control group.  
It is also possible that the differences between the ADHD and the control group 
reflect the complexity of the task, and that this complexity is more than just an 
additive effect of inhibition and set shifting. As such, it may be impossible to separate 
the functions, which is a view supported by Rabbitt (1997). However, it is also 
possible that the ADHD group have real problems with set shifting, and that this 
measure should be investigated further to determine if it could be used as an 
endophenotype for ADHD. Doyle et al. (2005) cited researchers who have linked 
components of executive functions to frontal systems (Willcutt et al., 2005) and 
argued that these components may constitute a core deficit that lies in the pathway 
that leads to behavioural symptoms in ADHD (Barkley, 2000; Castellanos & 
Tannock, 2002). However, several criteria have to be fulfilled for a measure to be 
considered an endophenotype. First, it should co-occur with the studied disorder, but 
it is not required to be universal for the disorder as it may be important for the 
understanding of heterogeneity in the condition. It should also be measured by 
instruments with good psychometric properties, be heritable and show familial-
genetic overlap with the studied disorder (Doyle et al., 2005). The second study 
included in this thesis suggested that set shifting as measured with the CWIT from the 
D-KEFS co-occurs with ADHD. It could also be argued that it has been measured 
with an instrument showing good psychometric properties. However, more research 
is required, especially to determine heritability and familial-genetic overlap with 
ADHD. Several problems are also related to genetic research and the use of 
neuropsychological endophenotypes in ADHD, and the reported findings have been 
difficult to replicate (Kebir & Joober, 2011). Recent studies also question the validity 
of EF endophenotypes (Thissen et al., 2013) in adults, showing that after childhood, 
most influence on ADHD seems to be genetically independent from the influence on 
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EF (Thissen et al., 2013). This suggests that EF may not be a pathway from genes to 
symptoms of adult ADHD. However, the authors pointed to the possibility that EF 
and ADHD may be aetiologically related in a subgroup of patients with ADHD. They 
also argued that the endophenotype construct of EF in ADHD is probably dependent 
on the stage of development. This is in line with the massive developmental changes 
that occurs in the brain through adolescence (Blakemore & Choudhury, 2006).  
4.1.4 Psychometrically defined EFD in ADHD- a subgroup 
characterized by functional impairment? 
In the first study, we chose to investigate dimensional symptoms by combining 
results in the ADHD and control groups, as well as examining subgroups within and 
across the groups. Such an approach may be useful as it could be questioned if 
examining group-differences between the ADHD and control-group is appropriate, 
considering the heterogeneous nature of the disorder. In accordance with this, we 
identified a subgroup with ADHD and psychometrically defined EFD in the third 
study. This group showed more functional impairment than the ADHD group without 
EFD. The group with ADHD and EFD was characterized by higher frequency of un-
employment, lower IQ, more self-reported ADHD-symptoms in childhood and more 
reading and writing problems. Interestingly, only 6.7% of the group with ADHD and 
EFD was employed, while this was true for 52.1% of the group with ADHD without 
EFD. In contrast, all participants were employed in the control group with EFD. This 
confirms studies showing that ADHD alone has a negative impact on work status 
(Halmoy et al., 2009), but that the combination of ADHD and EFD makes this even 
more severe (Biederman, Petty, et al., 2006), and that this combined group may 
represent a distinct subgroup.  
However, if ADHD is a disorder of EF, as Brown (2006) and Barkley et al. (2008) 
have suggested, it may not make sense to identify a subgroup with EFD. In this 
perspective, neuropsychological tests are not sufficient to discover the EF difficulties 
in ADHD. This is supported by Barkley & Fischer (2011), who found that rating 
scales were better to predict occupational functioning than neuropsychological EF 
 53 
tests in ADHD. However, they did not create a summary score for EF or defined 
”EFD” from the tests, but rather assessed the contribution of each test on the outcome 
variable. In our study, we used a cut-off for deficit including several tests from the 
same test battery, because previous studies have shown that a combination of tests is 
necessary to discriminate between ADHD groups and controls (Doyle, Biederman, 
Seidman, Weber, & Faraone, 2000). Still, more than 70% of the participants with 
ADHD in our study did not show EFD according to the definition, and the frequency 
of impairment in the ADHD and control group was not significantly different. 
However, results from our study indicate that this relatively small group of adults 
with ADHD is a vulnerable group with poor outcome. This highlights the importance 
of identifying this group, and supports previous research suggesting that ADHD is a 
highly heterogeneous condition.  
Nigg et al. (2005) have shown that there may be multiple pathways to ADHD, and 
suggested inclusion of a new subtype with EF deficits in DSM-5. They proposed that 
the strongest argument for such a new subtype would be if it could be possible to 
demonstrate that for some, the disorder is caused by EF problems, and as such is 
different from ADHD that is associated with other processes that are nonexecutive. 
They argued that this subgroup should represent a qualitatively different condition, or 
should change the risk for a certain negative outcome, not only increase the 
complexity of the disorder. The results from our third study indicate that the group 
with ADHD and EFD is at higher risk for certain negative outcomes than the group 
with ADHD alone, something that supports that the group with ADHD and EFD may 
be a distinct subgroup. However, we only found an association, and cannot assume 
that the functional impairments are caused by EFD. It could also be the other way 
around; that people without work develop EFD as a result of being out of work, or 
that lack of diagnosis and treatment in childhood leads to EFD. The latter was 
supported by the fact that none in the ADHD group with EFD had been diagnosed in 
childhood, compared to 12.7% in the ADHD group without EFD.  Studies showing 
that treatment in childhood is a strong predictor for being employed in adulthood also 
agree with this hypothesis (Halmoy et al., 2009). Another possibility is that the group 
with EFD and ADHD rather has more difficulties with compensating for the EF 
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problems than the ADHD group without EFD. Mahone (2002) suggested that 
individuals with ADHD and high IQ are better able to compensate for EF deficits 
than those with ADHD and low IQ, which may be the case in the group with EFD 
and ADHD in our study. This is in accordance with studies showing that IQ scores 
that lie below the average range may be correlated with several neuropsychological 
deficits, while this is not true for higher IQ scores (Dodrill, 1997, 1999). However, 
although we found a lower IQ in the group with EFD and ADHD, the IQ was still 
relatively high, suggesting that this explanation is unlikely.  We also did not find a 
correlation between IQ and D-KEFS subtests in the ADHD group with EFD, which 
indicates that although IQ in the ADHD group with EFD is lower than in the group 
without EFD, IQ is not directly associated with the deficit. 
Regardless if ADHD is a disorder of EF impairment or not, studies have shown that 
the subgroup displaying deficit on neuropsychological tests designed to measure EF 
are characterized by more functional impairment than the group without such 
difficulties. It is therefore of interest to examine those with ADHD and EFD 
combined, also at a genetic level, as this may lead us closer to identifying risk-factors 
for functional impairment in ADHD, with implications for clinical practice in terms 
of more targeted treatment.   
4.2 Methodological considerations 
In addition to the limitations already mentioned in the discussion, the studies included 
in this thesis have some methodological limitations that are important to take into 
consideration when interpreting the results. The study of complex neuropsychiatric 
disorders includes practical as well as theoretical challenges, some of which are 
described here. 
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4.2.1 Sample 
The participants in the main project were already diagnosed at different clinical sites 
when they were enrolled in the project. This may have given a more heterogeneous, 
but also a more ecologically representative and valid sample than in many other 
studies recruiting from one or a few specialized centres. The participants with ADHD 
in the present study were recruited according to two different procedures, resulting in 
samples that may have somewhat different characteristics. The participants recruited 
by the expert teams using common guidelines may reduce the diagnostic 
heterogeneity. In addition, this group may represent a chronically impaired 
subsample, as they were the first group of adults in Norway with ADHD considered 
for medication. On the other hand, the most affected individuals have probably not 
been able to follow the extensive inclusion procedure, where they should fill in the 
questionnaires, take a blood- or saliva test and send this through posted mail. This 
requires a certain degree of organization and planning, and could explain a response 
rate of approximately 20%, which may have led to an underestimation of difficulties 
related to ADHD in our study.  
The other part of the ADHD sample was directly recruited from clinicians. The vast 
majority were receiving treatment and may therefore represent patients that are more 
affected than if they were recruited from a community sample. The sample of patients 
is therefore consisting of two groups that are recruited slightly differently, and it may 
be that the effects level each other out. However, it is difficult to estimate exactly 
how these possible biases have influenced our sample, but the patients studied 
probably represent a population-based, naturalistic clinical setting, something that is 
crucial for the external validity of the findings. 
In the control group, the response-rate was about the same as in the ADHD group 
(20%). This also points to a bias towards the most well functioning individuals. 
However, it is also possible that the motivation for participating was low in this group 
because many do not have personal interest in the studied disorder. As such, there 
may be a bias towards a higher response-rate among persons with symptoms of 
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ADHD, or with family or friends with the disorder. This may have led to an 
underestimation of the true effects in the studies. 
4.2.2 Reported measures 
Questionnaires 
Self-report data were included in the present studies, and the participants may have 
been influenced by a wide range of factors modulating their symptom presentation on 
these questionnaires. Despite this, we believe that the information to the participants 
about anonymous treatment of data reduces this problem. A large part of the patients 
were on medication when filling in the questionnaires, which may have lowered the 
symptom-scores on the ASRS. The WURS assesses retrospective symptoms in 
childhood, and it could be difficult to remember childhood symptoms in adulthood. 
Awareness about the diagnosis of ADHD in adulthood may also lead to reporting 
more symptoms in childhood than were actually present. In some studies, high 
WURS scores have been related to a large number of false positives, and this 
indicates that it may partly reflect present personality instead of symptoms specific to 
ADHD (B. D. Hill, Pella, Singh, Jones, & Gouvier, 2009; Suhr, Zimak, Buelow, & 
Fox, 2009). However, although not officially validated in Norway, several studies 
have supported the validity of the questionnaires in Norway and comparable 
countries (Halmoy et al., 2009; Kessler et al., 2005; Luty et al., 2009), and they are 
widely used in both clinical- and research settings. 
Neuropsychological tests 
We used tests from the D-KEFS to examine EF in study 2 and 3. Because of the 
criticism from Crawford, Sutherland & Garthwaite (2008) concerning the validity and 
reliability of the D-KEFS contrast scores, we did not only include contrast measures 
in the second study, but also used an alternative statistical method to calculate “pure 
measures”.  Despite the criticism of the D-KEFS contrast measures, there are several 
reasons for using subtests from D-KEFS in the present project. This battery of tests 
represents the first standardized method for assessment of EF, and provides a 
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“cognitive-process” approach to testing, which also makes it possible to examine the 
process of task-solving, not only the outcome measure. D-KEFS is used extensively 
in clinical settings, something that makes studies including the tests more clinically 
relevant (Homack et al., 2005).  
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5. Conclusions 
The results from the first study support that COMT haplotypes should be studied in 
ADHD rather than only the val158met polymorphism. However, the fact that a 
significant association between symptoms and COMT haplotypes was found only in 
the medicated subgroup indicates that ADHD patients potentially can be divided into 
more subgroups than the subtypes described in the diagnostic manual (DSM-IV). The 
heterogeneity in ADHD was also supported by the third study, where we found that 
the group with psychometrically defined EFD and ADHD was significantly more 
functionally impaired than the group with ADHD without EFD. Several EF subtests 
from the D-KEFS were used to define the EFD, including the set shifting condition 
from the CWIT. This condition was shown to be the only test documenting 
significant differences between the ADHD and control group. These results are in 
accordance with the results from our second study, showing a significant difference 
for set shifting between the ADHD and control group also when controlling for basic 
functioning, IQ and working memory. Together, the present studies provide new 
knowledge that increases our understanding of the heterogeneity in ADHD.  
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6. Future perspectives 
The present thesis includes topics ranging from fundamental biological mechanisms 
to functional outcomes of ADHD and EFD. The first study was published in 2009, 
and reflects the state of molecular genetic research at that time. During the past five 
years, GWA studies have become very common, while candidate gene studies 
dominated the field in 2009. It has also become clear that the genetics of ADHD is 
highly complex, and that many different genes with small effects are involved in the 
disorder (Cross-Disorder Group of the Psychiatric Genomics et al., 2013; Franke et 
al., 2012; Martin, Hamshere, Stergiakouli, O'Donovan, & Thapar, 2014; Neale et al., 
2010; Yang et al., 2013). However, investigation of COMT haplotypes in ADHD had 
never been done when our study was published, and the interest in including 
haplotypes in future studies of ADHD and other neuropsychiatric disorders is 
illustrated by the many citations referring to this paper.  
The second study indicates that the set shifting condition from CWIT should be 
investigated in further studies, as the ADHD group showed impaired performance 
even after control for more basic functions. Although this finding was promising with 
regard to the validity of D-KEFS contrast measures, and indicated that this measure 
may be a potential endophenotype of ADHD, we cannot exclude other, alternative 
explanations of the finding. The measurement of EF is challenging. More complex 
designs that examine multiple EFs with the use of multiple exemplar tasks to define 
latent variables for the different EFs may be needed, as the use of a single, complex 
EF test makes it difficult to distinguish the multiple levels of genetic influence on EF 
(Friedman et al., 2008). 
In the third study, we also used the set shifting condition from the CWIT in addition 
to other EF tests from D-KEFS, to identify a subgroup with ADHD and EFD. 
Building on the experiences from the first study, it would be of interest to 
characterize this group genetically as this may give more insight into the genetic 
heterogeneity of ADHD. As genes highly expressed in specific regions in the brain 
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may also reflect functional specialisation, such studies may benefit from linking brain 
regions related to different EFs to sets of genes expressed in these brain regions 
(Ersland et al., 2012). However, since many genes with small effects probably are 
involved in ADHD, large samples are needed, which could be challenging in studies 
where neuropsychological testing is required. Multicentre studies with close 
collaboration concerning test procedures to secure high reliability between centres 
would improve the chance to obtain large samples with adequate power. In the future, 
functional outcome studies using national registry data with millions of records may 
also provide more insight into the nature of ADHD, especially if this could be linked 
to genetic information or other biomarkers. 
In addition, to deal with the heterogeneity and complexity in ADHD, a more ” 
personalized” psychiatric research approach, examining what characterizes 
individuals displaying certain features (or lack of such features), may be important to 
get more knowledge about the individuals within and across the present diagnostic 
categories. As a diagnosis is basically made by counting descriptive symptoms, there 
are arguments for establishing new classifications systems for psychiatric disorders. 
The Research Domain Criteria project (RDoC) has been launched by National 
Institute of Mental Health (NIMH) to define basic dimensions of functioning, 
including genes, neural circuits, as well as basic behavioural and neurobiological 
research. This could lead to a more integrative understanding of psychopathology in 
addition to better treatment. The background for this project was the lack of clearly 
defined subtypes of mental disease, without specific biological findings. This led to 
the question if this specificity may exist, but not necessarily for the clinical categories 
that are recognized today. The RDOC project takes a dimensional approach that 
spans from normal to abnormal function, and aims to generate classifications based 
on neurobiological underpinnings (Insel et al., 2010). This represents a relatively new 
perspective on psychiatric disorders, and may also generate more knowledge about 
the heterogeneity of ADHD in the future.  
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